Eli Lilly Revenue 2012-2026 | LLY

Eli Lilly revenue for the twelve months ending March 31, 2026 was $72.250B, a 47.44% increase year-over-year.

  • Eli Lilly annual revenue for 2025 was $65.179B, a 44.7% increase from 2024.
  • Eli Lilly annual revenue for 2024 was $45.043B, a 32% increase from 2023.
  • Eli Lilly annual revenue for 2023 was $34.124B, a 19.56% increase from 2022.

Eli Lilly Revenue 2012-2026 | LLY

  • Eli Lilly annual revenue for 2025 was $65.179B, a 44.7% increase from 2024.
  • Eli Lilly annual revenue for 2024 was $45.043B, a 32% increase from 2023.
  • Eli Lilly annual revenue for 2023 was $34.124B, a 19.56% increase from 2022.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B